Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 24.08.2026 2 Acta Neuropathol 1 BMC Cancer 1 BMC Neurol 3 Childs Nerv Syst 2 Eur J Cancer 2 J Clin Oncol 7 J Neurooncol 1 J Neuropathol Exp Neurol 1 Nat Rev Cancer 4 Neuro Oncol 1 Neuroradiology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. PEARCE TM, Cimino PJ, Lucas CG, Marker DF, et al
   Sellar region neurocytomas exhibit a CIMP and neuroendocrine-like epigenetic signature distinct from other intra-axial neurocytomas.
   Acta Neuropathol. 2026;152:20.
   PubMed         Abstract available
   
   
2. TAUZIEDE-ESPARIAT A, Metais A, Aldape K, Singh O, et al
   Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity.
   Acta Neuropathol. 2026;152:22.
   PubMed        
   
   

   
   BMC Cancer

3. LIN YJ, He MY, Xie Y, Yin ZY, et al
   Evaluation of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in non-small cell lung cancer: a prospective cohort study.
   BMC Cancer. 2026 Jun 11. doi: 10.1186/s12885-026-16325.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. ZHANG Y, Chai X, Hu Y, Deng K, et al
   Comprehensive characterization and prognostic analysis of multifocal intracranial germ cell tumors.
   BMC Neurol. 2026;26:535.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

5. DASSI N, Figueiredo MLS, Gamba FT, da Costa MDS, et al
   Reirradiation for diffuse intrinsic pontine glioma in an upper middle-income country: does full dose improve outcomes?
   Childs Nerv Syst. 2026;42:340.
   PubMed         Abstract available
   
   
6. STOLTZFUS MT, Hong J, Harbaugh T, Sherman J, et al
   A rare case of primary cardiac sarcoma with both intracranial metastasis and embolic infarction in a pediatric patient.
   Childs Nerv Syst. 2026;42:336.
   PubMed         Abstract available
   
   
7. IGLESIAS S, Becerra V, Miranda P, Marquez T, et al
   Clinical, molecular, and surgical predictors of outcome in non-DIPG pediatric diffuse midline gliomas: A collaborative retrospective analysis.
   Childs Nerv Syst. 2026;42:341.
   PubMed         Abstract available
   
   

   
   Eur J Cancer

8. STEINDL A, Starzer AM, Tomasich E, Kleinberger M, et al
   Immune remodelling and molecular profiling of progressive brain metastases following cranial radiotherapy.
   Eur J Cancer. 2026;246:116988.
   PubMed         Abstract available
   
   
9. DRIJVER AJ, Butterbrod E, Hertler C, Frances SM, et al
   Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
   Eur J Cancer. 2026;246:116985.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

10. LEUTHARDT EC, Chiang V, Hadjipanayis CG, Landazuri P, et al
    Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
    J Clin Oncol. 2026 Aug 17:JCO2502604. doi: 10.1200/JCO-25-02604.
    PubMed         Abstract available
    
    
11. WILSON MR, Lewis KL, Kirkwood AA, Cwynarski K, et al
    High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
    J Clin Oncol. 2026 Jun 11:JCO2600947. doi: 10.1200/JCO-26-00947.
    PubMed         Abstract available
    
    

    
    J Neurooncol

12. OH HC, Yoo J, Ahn SJ, Hong CK, et al
    Cyst wall enhancement is associated with local recurrence after resection of intracranial hemangioblastoma: an exploratory retrospective cohort study.
    J Neurooncol. 2026;179:48.
    PubMed         Abstract available
    
    
13. ZERWECK L, Schmidlechner T, Stumpo V, Jehli E, et al
    Hypoxia-targeted BOLD MRI signal heterogeneity as a complementary metric for glioblastoma characterization: a pilot study.
    J Neurooncol. 2026;179:47.
    PubMed         Abstract available
    
    
14. HE J, Kang M, Wang Y, Li R, et al
    Anatomical and surgical factors associated with postoperative hydrocephalus after central neurocytoma resection: a large single-center cohort study.
    J Neurooncol. 2026;179:46.
    PubMed         Abstract available
    
    
15. MILLER M, Strojny D, Sobanski D, Staszkiewicz R, et al
    Differential expression of TGF-beta1, TGF-beta2, and TGF-beta3 across WHO grades in meningioma: convergent evidence from mRNA, methylation, miRNA, and protein analysis.
    J Neurooncol. 2026;179:42.
    PubMed         Abstract available
    
    
16. ZATZMAN C, Fernandes I, Kojundzic I, D'Souza N, et al
    Exclusion of patients with brain metastases from early-phase systemic therapy trials: a cross-sectional analysis of eligibility criteria.
    J Neurooncol. 2026;179:43.
    PubMed         Abstract available
    
    
17. KRAUS LM, Goldberg M, Backhaus PS, Albrecht C, et al
    Treatment selection and functional outcomes in motor cortex metastases.
    J Neurooncol. 2026;179:41.
    PubMed         Abstract available
    
    
18. MANORANJAN B, Zeller S, Price H, Reiner AS, et al
    Clinical and genomic characterization of brain metastasis in bladder cancer.
    J Neurooncol. 2026;179:44.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

19. RAQUIB AR, Schwartz SN, Siddiqi SH, Varma H, et al
    An open-source application for automated quantification of Ki-67 proliferative index in meningiomas.
    J Neuropathol Exp Neurol. 2026 Aug 21:nlag083. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

20. ENGELHARDT B, Platten M
    Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.
    Nat Rev Cancer. 2026 Aug 20. doi: 10.1038/s41568-026-00960.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

21. 
    Corrigendum to: Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.
    Neuro Oncol. 2026 Aug 20:noag176. doi: 10.1093.
    PubMed        
    
    
22. WEN PY, Nakhate V, van den Bent MJ
    What are "high-risk" grade 2 IDH-mutant gliomas requiring radiochemotherapy?
    Neuro Oncol. 2026 Aug 19:noag197. doi: 10.1093.
    PubMed        
    
    
23. BRAMAN BC, Nguyen MP, Mirchia K, Morshed RA, et al
    Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups.
    Neuro Oncol. 2026 Aug 19:noag196. doi: 10.1093.
    PubMed         Abstract available
    
    
24. PERUMALSAMY B, Vengoji R, Thiraviyam A, Ramireddy I, et al
    Abexinostat attenuates temozolomide-resistant glioma stem cells.
    Neuro Oncol. 2026 Aug 19:noag193. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

25. DE WILDE D, Zanier O, Alakmeh A, Voglis S, et al
    Automated deep learning-based segmentation and volumetric analysis of meningiomas.
    Neuroradiology. 2026 Aug 20. doi: 10.1007/s00234-026-04152.
    PubMed         Abstract available
    
    

    
    PLoS One

26. MULVANY T, Griffiths-King D, Worthington L, Crombie K, et al
    Evaluating the impact of segmentation strategies on radiomic feature stability for paediatric brain tumour diagnosis using diffusion weighted imaging.
    PLoS One. 2026;21:e0356382.
    PubMed         Abstract available
    
    
27. VEENSTRA JL, Schwartz SA, Speth JP, Geise JB, et al
    Comparison of methods for in vivo and ex vivo quantification of iron in murine brain tumors.
    PLoS One. 2026;21:e0356378.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum